Outer Membrane: Gram-Negative Bacterial Layers

Explore the outer membrane of Gram-negative bacteria, its structure, functions, and role in pathogenesis, as well as methods used to study its properties.

Gram-negative bacteria are wrapped in a double-membrane envelope, and the outer membrane is the layer that makes them so stubbornly hard to kill. Unlike the single cytoplasmic membrane found in all bacteria, this second, outermost bilayer is chemically lopsided: its outer face is dominated by lipopolysaccharides (LPS) while its inner face consists of ordinary phospholipids. That asymmetry, combined with a dense network of channel proteins and physical tethering to a rigid scaffold underneath, creates a barrier that blocks most antibiotics, shapes how the immune system detects infection, and gives these organisms a survival edge in almost every environment on Earth.

An Asymmetric Lipid Bilayer

Most biological membranes have roughly the same types of lipids on both sides. The gram-negative outer membrane breaks that rule. Its inner leaflet is a phospholipid mixture, much like any other membrane, but its outer leaflet is built almost entirely from glycolipids. In the vast majority of gram-negative species those glycolipids are lipopolysaccharides; a few species use glycosphingolipids instead. The result is a membrane whose two halves have completely different chemistry, charge, and permeability.

Maintaining that asymmetry is an active process. Phospholipids sometimes flip into the outer leaflet where they don’t belong, and the cell has to remove them. An ABC transport system in the outer membrane recognizes misplaced phospholipids and shuttles them back to the inner leaflet, restoring the normal lipid distribution. When that maintenance breaks down, the outer membrane becomes leakier and the bacteria become more vulnerable to detergents and antibiotics. The asymmetry is not a passive structural accident but an energy-consuming feature that the cell constantly polices.

Channels, Barrels, and How Molecules Get Through

A lipid barrier alone would starve the cell. Gram-negative bacteria solve this by studding the outer membrane with protein channels. The most abundant are porins, water-filled transmembrane channels shaped like barrels. General porins such as OmpF allow small hydrophilic molecules like sugars, amino acids, and certain ions to diffuse through. Charged amino acids lining these channels determine which molecules pass easily and which are excluded, acting more like a selective filter than an open pipe.

Porins work fine for nutrients that are small and abundant. But some critical resources, particularly iron, are too scarce in the host environment to rely on passive diffusion. For those, gram-negative bacteria use a family of specialized outer membrane receptors called TonB-dependent transporters. These proteins bind iron-carrying molecules called siderophores, as well as vitamin B12 and certain carbohydrates, and pull them through using energy transmitted from the inner membrane. The energy source is the proton motive force, a voltage gradient across the inner membrane, which gets relayed to the outer membrane receptor by a three-protein complex consisting of TonB, ExbB, and ExbD. This arrangement is unusual: the outer membrane has no energy source of its own, so it essentially borrows power from the inner membrane through a molecular relay chain.

Building and Maintaining the Outer Membrane

The outer membrane sits outside the peptidoglycan cell wall and far from the cytoplasm where proteins and lipids are made. Getting all its components into position requires dedicated transport systems, each handling a different class of molecule.

Moving LPS to the Surface

Lipopolysaccharide is synthesized at the inner membrane, then ferried across the periplasm and inserted into the outer leaflet by the Lpt (lipopolysaccharide transport) pathway. The system works somewhat like a PEZ dispenser: energy from ATP in the cytoplasm pushes LPS molecules one after another through a continuous protein bridge that spans the entire cell envelope, from the inner membrane through the periplasm to the outer membrane surface. The bridge is formed by a chain of Lpt proteins (LptB, LptC, LptA, and LptD), with each component handing LPS to the next in line.

Inserting Outer Membrane Proteins

Outer membrane proteins are beta-barrels, cylindrical structures made of folded protein sheets. They are synthesized in the cytoplasm, threaded across the inner membrane, and then chaperoned through the periplasm in an unfolded state. The final folding and insertion step is handled by the BAM (beta-barrel assembly machinery) complex, anchored in the outer membrane itself. Structural studies show that BAM’s central component, BamA, has a barrel whose strands physically shift to open a lateral gate, allowing the new protein to slide sideways into the lipid bilayer. A periplasmic chaperone called SurA delivers unfolded proteins to BAM by binding at its soluble domain, triggering the conformational changes needed for insertion. Remarkably, once the BAM complex is working, it can fold proteins efficiently regardless of the surrounding lipid composition, suggesting it largely overrides the effects of lipid chemistry on assembly.

Sorting Lipoproteins

The outer membrane also carries lipoproteins, proteins anchored to the membrane by a lipid tail. These are sorted to the outer membrane by the Lol export pathway, which begins with the ABC transporter LolCDE. This complex selectively extracts the right lipoproteins from the inner membrane and hands them off for trafficking across the periplasm. Traditionally, the periplasmic chaperone LolA and its outer membrane receptor LolB were considered absolutely essential for delivering lipoproteins to their destination. But research has shown that cells can completely bypass both of these proteins under certain stress conditions, as long as they activate envelope stress responses that prevent the toxic buildup of mislocalized lipoproteins. In other words, the main role of LolA and LolB is not performing an irreplaceable mechanical step but rather serving as quality control to keep things from going wrong.

The Peptidoglycan Connection

Sitting between the inner and outer membranes is the peptidoglycan layer, a mesh-like scaffold that gives the cell its shape. The outer membrane does not just hover above this scaffold; it is physically bolted to it. The most prominent bolt is Braun’s lipoprotein, known as Lpp, which is the most abundant protein in Escherichia coli. Lpp has a lipid tail embedded in the outer membrane and its other end covalently attached to the peptidoglycan. About one-third of Lpp molecules form this covalent cross-link, which is carried out by a set of transpeptidase enzymes. This tethering is critical for the outer membrane to work as a permeability barrier against antibiotics and toxins.

Without Lpp attachments, the outer membrane peels away from the cell wall and can no longer exclude harmful molecules effectively. Scientists have also identified an enzyme, DpaA, that detaches Lpp from peptidoglycan, suggesting the system is dynamic, with cross-links being both formed and broken as the cell grows and divides.

Endotoxin and the Immune Response

The LPS that covers the outer surface of gram-negative bacteria is not just a structural component. It is also an endotoxin, one of the most potent triggers of the innate immune system. The active portion is lipid A, the anchor that holds LPS in the membrane. When gram-negative bacteria die and release LPS, or when fragments reach the bloodstream, the immune system reacts strongly. Lipid A binds to a receptor complex involving Toll-like receptor 4 (TLR4) and its co-receptor MD-2 on immune cells. This triggers a burst of inflammatory cytokines and leukocyte activation that helps clear localized infections. But at high doses, the response can spiral into systemic inflammation and septic shock.

Many gram-negative pathogens have evolved tricks to dampen or dodge this immune recognition. One strategy involves modifying lipid A itself. The PhoP/PhoQ two-component signaling system, found in bacteria like Salmonella, senses environmental cues including low magnesium and the presence of antimicrobial peptides, then switches on genes that chemically alter lipid A. Modifications such as adding aminoarabinose or hydroxymyristate change how immune cells respond to the molecule, reducing the inflammatory signal and helping the bacterium survive inside host tissues. Another evasion tactic involves the O-antigen polysaccharide chains that extend outward from LPS. Long O-antigen chains can interfere with the complement system, a cascade of proteins that punches holes in bacterial membranes. Some species go further and decorate their O-antigen with sugar residues that mimic human carbohydrates, effectively disguising themselves. Helicobacter pylori, for example, adds fucose residues to produce Lewis antigens identical to those on the human gastric lining.

The Antibiotic Problem

The outer membrane is the main reason gram-negative infections are so much harder to treat than gram-positive ones. Most clinical antibiotics lack activity against gram-negative pathogens, largely because they cannot get past this barrier. Antibiotics that do penetrate take one of two routes: hydrophobic drugs dissolve through the LPS-laden lipid bilayer, while hydrophilic drugs diffuse through porins. Both routes are narrow. The tightly packed LPS layer resists entry of most hydrophobic compounds, and porins are small enough to exclude anything much larger than a simple sugar.

Even drugs that make it inside often get immediately expelled. Gram-negative bacteria run tripartite efflux pumps that span both membranes and the periplasm, actively pumping a huge range of chemically unrelated compounds back out of the cell. The best studied is AcrAB-TolC in E. coli: AcrB in the inner membrane captures drugs, AcrA bridges the periplasm, and TolC in the outer membrane ejects them. The breadth of substrates this single pump handles is remarkable, covering antibiotics with little chemical similarity to one another. For a drug to work, it needs to enter faster than the pump can throw it out, a race that many antibiotics lose.

Polymyxins, a class of lipopeptide antibiotics, represent one of the few drug families that directly attack the outer membrane. They target lipid A, binding to it electrostatically and displacing the divalent cations (calcium and magnesium) that normally stabilize LPS packing. Once bound, polymyxin molecules fold into a conformation that lets them penetrate the hydrophobic core of the membrane, causing local disorganization and dramatically increasing permeability. Polymyxins are often called “last resort” drugs because of their kidney toxicity, so there is intense interest in finding new ways to breach the outer membrane.

One promising approach targets the BAM complex. Because BamA sits on the bacterial surface and is essential for inserting all other outer membrane proteins, disabling it collapses the entire outer membrane. Researchers computationally identified a novel peptide antibiotic called dynobactin A, produced naturally by a bacterium called Photorhabdus australis, which binds BamA and kills gram-negative bacteria. Dynobactin is structurally unrelated to earlier BamA-targeting compounds like darobactin but hits the same target, suggesting that BamA inhibition is a viable and potentially broad antibiotic strategy.

Outer Membrane Vesicles

Gram-negative bacteria routinely bleb off small spherical packages from their outer membrane. These outer membrane vesicles (OMVs) are essentially little bubbles of outer membrane filled with periplasmic cargo, including enzymes, toxins, signaling molecules, and DNA. They form at sites where the outer membrane has fewer connections to the underlying peptidoglycan, and the process does not require direct energy from ATP.

OMVs serve a surprising number of functions. They deliver virulence factors to host cells during infection, allow bacterial populations to communicate at a distance, help with nutrient acquisition, and contribute to biofilm formation. They also play a role in stress responses: vesicle production ramps up when bacteria encounter envelope stress, essentially allowing the cell to jettison damaged material. Because OMVs carry LPS and other bacterial surface molecules, they also stimulate the immune system, which has made them attractive as a platform for vaccine development. Engineered OMVs are already being explored for immunization against bacterial pathogens and even as targeted drug delivery vehicles.

The Outer Membrane in Bacterial Competition

The outer membrane is not just a passive shield against the host immune system and antibiotics. It also plays a role in warfare between bacterial species. Some bacteria inject toxic effector proteins into rival cells using the type VI secretion system (T6SS), a molecular syringe. For certain toxins to enter a target cell, they need to pass through the target’s outer membrane by hijacking specific outer membrane proteins. The T6SS effector Tce1, for instance, requires the porin OmpF and the vitamin B12 receptor BtuB in the outer membrane of target cells to gain entry. This means the very channels that a cell depends on for nutrients can become entry points for weapons produced by competitors, a vulnerability built into the outer membrane’s design.

Evolutionary Origins of the Double Membrane

For a long time, the gram-positive/gram-negative division was treated as a clean dichotomy. But phylogenetic studies have blurred that boundary. Some members of the Firmicutes, a phylum traditionally classified as gram-positive, actually have an outer membrane, making them diderms (two-membrane cells). Genomic analysis suggests that the diderm (double-membrane) arrangement may be the ancestral condition for most bacteria, and that the single-membrane gram-positive phenotype arose independently multiple times through loss of the outer membrane rather than the other way around.

Across the broader bacterial tree of life, two major clades have been recognized: the Gracilicutes, which are strictly diderm, and the Terrabacteria, which include both monoderm and diderm species with a range of cell envelope architectures. Understanding which gains and losses of the outer membrane have occurred across the tree helps researchers piece together what the earliest bacterial cells looked like, and may even offer clues about the last common ancestor of all bacteria. The outer membrane, in other words, is not just a defining feature of a bacterial group but a window into some of the deepest questions in microbial evolution.

How Biofilms Use Outer Membrane Components

When gram-negative bacteria form biofilms, the extracellular matrix that holds the community together draws on outer membrane-associated components. Cell surface adhesins and appendages like pili and flagella, many of which are anchored in or pass through the outer membrane, initiate attachment to surfaces and to neighboring cells. As the biofilm matures, secreted proteins stabilize the matrix by interacting with polysaccharides and extracellular DNA, and the three-dimensional architecture of the community depends in part on these surface-exposed structures. Biofilm dispersal, too, involves enzymatic breakdown of matrix components, including outer membrane-associated proteins. The outer membrane is therefore not just a barrier around individual cells but a contributor to the collective structures that make biofilm infections so persistent and difficult to treat.